igmbio.com (IGMS) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
IGM Biosciences, Inc. (IGMS) narxining evolyutsiyasi noyob patentlangan yechimlardan foydalangan holda autoimmun patologiyalarni davolash uchun ilg'or IgM antitanachalarini yaratishga asoslangan aktiv dinamikasini aks ettiradi. Brend keyingi avlod anti-tumor agentlarini ishlab chiqish bo'yicha ekspert sifatida tan olingan bo'lib, ko'rsatkich 0.00 darajasida turibdi. Fan uchun bio-protein ta'minotining barqarorligi global laboratoriyalar tarmog'i va tezlashtirilgan havo yuk tashuvlari orqali kafolatlanadi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvvwvvs9.gq-7b28iyo&start=20220704&end=20261031&filename=GURU_Markets_-_IGMS_-_IGM-Biosciences-Inc._-_Long-Term-Debt-to-Capital "IGMS: IGM Bio Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 24.08.2025 | 👁️GURU.Markets👁️")
IGM Biosciences Inc. (IGMS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati IGM Biosciences, Inc.|IGMS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati IGM Bio|IGMS - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati IGM Biosciences, Inc.|IGMS - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi IGM Biosciences|Tezkor likvidlik ko‘rsatkichi igmbio.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:igmbio.com - IGMS
Ushbu koeffitsiyent kompaniya kapitaliga nisbatan uzoq muddatli qarz majburiyatlarining ulushini belgilaydi. Koeffitsiyentning kamayishi moliyaviy avtonomiyaning ortganligini anglatadi, ammo haddan tashqari konservativlik rivojlanish sur'atlarini cheklashi mumkin. Uzoq muddatli qarzning kapitalga nisbati dinamikasini tahlil qilish orqali investor moliyalashtirish tuzilmasining barqarorligini baholaydi. IGM Biosciences , Inc. (IGMS) uchun past qarz yuklamasi innovatsion IgM antitelalarni ishlab chiqishda hal qiluvchi ahamiyatga ega. Sog'liqni saqlash gigantlari bilan strategik ittifoqlar minimal qarz olish imkonini beradi va klinik sinovlar risklarini kamaytiradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Pieris Corp PVLA|SVRA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati rigel.com RIGL|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|Uzoq muddatli qarzning o'z kapitaliga nisbati Astria Therapeutics Inc (ATXS)|Uzoq muddatli qarzning o'z kapitaliga nisbati ENGN (enGene Bio)|RAPT (rapt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati JBIO (Aerovate Therapeutics)|aclaristx.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Kyverna Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Tiziana Life Sciences Ltd. TLSA|Cabaletta Bio, Inc (CABA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Ventyx Biosciences, Inc (VTYX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Theratechnologies Inc.|avalotx.com (AVTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ELDN|Uzoq muddatli qarzning o'z kapitaliga nisbati Agenus, Inc. AGEN|Uzoq muddatli qarzning kapitalga nisbati CLYM (Climb Bio, Inc.)|Uzoq muddatli qarzdorlikning kapitalga nisbati zurabio.com (ZURA)|aTyr Pharma, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Adagene|ikenaoncology.com (IMA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi STTK|EQ (Equillium Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Connect Pharma (CNTB)|Uzoq muddatli qarzning kapitalga nisbati IMUX|ATRA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati InflaRx IFRX|Uzoq muddatli qarzdorlikning kapitalga nisbati X4 Pharmaceuticals Inc. (XFOR)|ACET: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CELU (Celularity Inc.)|INMB: Uzoq muddatli qarzning kapitalga nisbati|BRNS - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Kezar Life Sciences, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi SABS (SAB Biotherapeutics Inc.)|Uzoq muddatli qarzning kapitalga nisbati AKTX|Uzoq muddatli qarzning o'z kapitaliga nisbati enlivex.com ENLV|Q32 Bio - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati geovax.com (GOVX)|Edesa Biotech - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati iBio Inc IBIO|CARM: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati XTL Bio XTLB|Uzoq muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics Inc (HCWB)|Uzoq muddatli qarzning o'z kapitaliga nisbati Aptevo Therapeutics (APVO)|Uzoq muddatli qarzdorlikning kapitalga nisbati aimimmuno.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Aditxt, Inc. ADTX|GRI (GRI Bio Corporation) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|XORTX Therapeutics Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti HIND (reshapelifesciences.com)|REVB: Uzoq muddatli qarzning kapitalga nisbati|Indaptus Therapeutics Inc (INDP) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Scinai|CALI: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Affimed (AFMD)|Uzoq muddatli qarzning o'z kapitaliga nisbati allakos.com ALLK|Uzoq muddatli qarzning kapitalga nisbati HOOK (HOOKIPA Pharma)|Uzoq muddatli qarzning kapitalga nisbati iTeos Therapeutics Inc ITOS|OCEA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|THRD: Uzoq muddatli qarzning kapitalga nisbati